Pain in the back of your knee when walking? Learn the causes, symptoms, and best treatments to relieve discomfort and prevent ...

The Phase II trial is a double-blind, placebo-controlled study designed to evaluate safety and efficacy, with key outcomes focusing on joint pain and function assessed over several months.

The diabetes drug metformin provided overweight/obese patients with osteoarthritis (OA) of the knee with significantly ...

Enlivex anticipates releasing topline data from the Phase II stage, including full three-month endpoints, by this August.

Osteoarthritis ... linked joint pain to an increased risk for falls. The more joints arthritis affects, the greater the odds you’ll take a tumble. In a 2015 Arthritis Care & Research study, people ...

Background Mechanical joint stress imposed by high body mass index (BMI) is associated with increased risk of knee and hip osteoarthritis. This prospective study investigated the independent and joint ...

Abstract: Knee Osteoarthritis (KOA) is a degenerative musculoskeletal joint disorder that significantly impacts middle-aged and elderly individuals. Although X-rays and MRIs are clinically used to ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.

Results presented here showed intra-articular injections of platelet-rich plasma may be inferior to corticosteroid injections ...